Derogation for expired CE Certificates

The Medical Devices Regulation (MDR) foresees a transitional period for medical devices assessed under the previous Directives. With the initial 2024 deadlines and limited conformity assessment capacity, too many devices might have become unavailable on the market. In order to prevent market disruptions and protect patients’ safety, the European Union mobilised and introduced longer transitional provisions.

Schedule a Call

Your Representative of choice for

Under certain conditions, medical devices are subject to a longer transitional period and extended certificate validity automatically. Nonetheless, this applies only to medical devices with a CE Certificate that expired from 20 March 2023, the publication date of the new amendments.

Medical devices with a CE Certificate expired before 20 March 2023 have three options if they wish to still place their devices on the EU market:

  1. Applying for a derogation under Article 59.
  2. Having a signed agreement with a Notified Body before the Certificate has expired.
  3. Complete conformity assessment procedure under MDR and obtain MDR CE Certificate from Notified Body.

Upon the certificate’s expiration (expired before 20 March 2023), the Authorised Representative of a non-EU manufacturer can apply for a derogation under Article 59. The Competent Authority will evaluate the application and – if they consider that the device does not represent a health and safety risk – can grant a derogation, allowing the manufacturer to keep placing their medical devices on the market for a defined period of time.

Obelis, Authorised Representative based in Brussels, Belgium, applies on behalf of the manufacturer for a derogation with the Belgian Competent Authority under Article 59. The Belgian Competent Authority (AFMPS) will assess the application and – based on the data received – evaluate whether to proceed with Article 59. In this case, the manufacturer receives a national derogation under specific circumstances.

Compliance Success Stories

Why Obelis?

Our deep and long-standing experience with Swiss, EU and UK compliance frameworks makes us the best choice to support your products’ path towards compliance in these territories.

Our team regulatory experts will guide you through medical devices’ technical documentation, notification, labelling, among others.

About us
Founded in 1988, we are among Europe’s largest centres for advisory and representative services.
We are certified by ISO 9001:2015 and ISO 13485:2016.
We have helped over 3,000 manufacturers from over 60 countries address their regulatory challenges.
We are members of professional associations and more than 10 European Commission working groups.
Obelis International Offices (OIO) comprise independent partners providing solutions in other global markets.
Our team consists of lawyers, chemists, pharmacists, and other experts. Our close-knit culture has been certified by the Great Place to Work Survey 2022-23.